The U.S. Supreme Court on Tuesday granted a request from the U.S. Food and Drug Administration to reinstate restrictions on mifepristone, a drug commonly referred to as the “abortion pill.” The Court’s decision reinstates a requirement for patients to pick up the drug in person. Three lower courts had blocked the FDA’s in-person pickup requirement for mifepristone during the coronavirus…
Want to read the full article and more?

Share with others:

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email